Posts by Andrew Alan Nierenberg, MD
-
Familial Psychiatric Burden High in Bipolar Disorder but Not Correlated with Treatment Response
Andrew A. Nierenberg, MD, and colleagues determined that 85% of patients with bipolar disorder have at least one first-degree family member with a severe psychiatric disorder, but intensive treatment can lead to treatment outcomes comparable to those of patients without a familial psychiatric history.
-
Novel Drug Target Proposed for Bipolar Disorder
Certain antidiabetic drugs that target PGC-1α, which regulates metabolism and inflammation, are being investigated for their efficacy against bipolar disorder.
Biography
Andrew A. Nierenberg, MD, holds the Thomas P. Hackett, MD, Endowed Chair in Psychiatry at Massachusetts General and is the director of the Dauten Family Center for Bipolar Treatment Innovation, associate director of the Depression Clinical and Research Program, and director of Center for Clinical Research Education, Division of Clinical Research, Mass General Research Institute. Dr. Nierenberg’s academic appointment is professor of psychiatry at Harvard Medical School. He has published over 470 papers and has been listed among the Best Doctors in North America for the treatment of mood and anxiety disorders continuously since 1994.
He has received the National Depression and Manic Depression Association (NDMDA), Depression and Bipolar Support Alliance Gerald L. Klerman Young Investigator and Senior Investigator Awards and the Mass General Psychiatry Mentorship Award. Additionally, Dr. Nierenberg has been awarded the Brain and Behavior Research Foundation Colvin Prize for outstanding achievement in mood disorders research and was listed among the World’s Most Influential Scientific Minds in 2014, 2015, 2016 and 2017 by Clarivate for being in the top 1% of literature citations in psychiatry or psychology worldwide.
In his spare time, Dr. Nierenberg is an avid cyclist and a struggling tenor and soprano saxophone player.
